b C2 (Pramipexole dihydrochloride 0.125 mg)

Pill imprint b C2 has been identified as Pramipexole dihydrochloride 0.125 mg.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.125 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for b C2

Pramipexole dihydrochloride 0.125 mg b C2
Pramipexole dihydrochloride 0.125 mg b C2
Pramipexole dihydrochloride 0.125 mg b C2
Pramipexole dihydrochloride
Imprint:
b
C2
Strength:
0.125 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00555-0617
Inactive Ingredients:
corn starch
mannitol
povidone

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)